jump there. Now, we've got more news on Astroenica. We were talking about this a few days ago.Angelica Peeles has the details for us. Hi, Angelica. Hey there.That's right. So, Bloomberg is reporting that Astroenica is in talks with Summit Therapeutics to license the company's experimental lung cancer drug for up to $15 billion. Now, Bloomberg is attributing this to people familiar with the matter.Now, this has been an incredibly hot area of development. Summit has really um shephered this whole field. this ...